FindTrial
Sign In

Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)

Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030219
Enrollment
Unknown
Registered
2020-02-25
Start date
2020-01-21
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Integration of traditional Chinese and Western Medicine

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 91 Years

Inclusion criteria

Inclusion criteria: 1) Any age; 2) Meet the diagnostic standard of COVID-19; 3) Voluntarily accept TCM syndrome differentiation treatment; 4) Agree to sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Liver and kidney dysfunction (alt, AST > 2 times the upper limit of normal reference value or / and serum creatinine > 2 times the upper limit of normal reference value); 2) Psychosis, or cognitive impairment; 3) Those who are unwilling to cooperate with information collection.

Design outcomes

Primary

MeasureTime frame
Clinical symptoms;TCM syndrome;Lung imaging;Time of nucleic acid turning negative;—

Secondary

MeasureTime frame
Routine blood test;C-reactive protein;—

Countries

China

Contacts

Public ContactBi Ying-fei

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

yingfei1981@163.com+86 13920648942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026